Nagai-Kusuhara Azusa, Nakamura Makoto, Fujioka Miyuki, Negi Akira
Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Graefes Arch Clin Exp Ophthalmol. 2008 Apr;246(4):567-71. doi: 10.1007/s00417-007-0727-x. Epub 2007 Dec 11.
To report long-term results of amniotic membrane transplantation (AMT)-assisted bleb revision for intractable late-onset bleb leak.
Retrospective medical record review of six consecutive patients who underwent AMT-assisted bleb revision for late-onset bleb leak at the Kobe University hospital between December 2001 and March 2004.
The median (range) of age was 60 (20-77) years. All patients had a history of trabeculectomy with adjunctive use of 0.4 mg/ml mitomycin C. The median (range) of interval between the prior trabeculectomy and bleb leak was 15 (4-54) months. Preoperative intraocular pressure (IOP) was lower than 10 mmHg in two cases, while it was 25 mmHg or higher in three patients, who had a localized, ischemic, thin-wall leaking bleb circumscribed with extensively scarred tissue. The median (range) of follow-up after the AMT-assisted bleb revision was 49 (41-67) months. Postoperative IOP was well controlled in all patients without medication or with a maximum of three glaucoma medications. No patients presented recurrence of the bleb leak or AMT-related complications during entire follow-up. All patients showed at final visit a diffuse bleb which extended posteriorly beyond the conjunctival incision line.
AMT-assisted bleb revision successfully treated intractable late-onset bleb leak. Further comparative studies are needed to confirm the present result.
报告羊膜移植(AMT)辅助难治性迟发性滤过泡渗漏修补术的长期结果。
回顾性分析2001年12月至2004年3月在神户大学医院接受AMT辅助难治性迟发性滤过泡渗漏修补术的6例连续患者的病历。
年龄中位数(范围)为60(20 - 77)岁。所有患者均有小梁切除术史,并辅助使用0.4mg/ml丝裂霉素C。前次小梁切除术与滤过泡渗漏之间的间隔时间中位数(范围)为15(4 - 54)个月。术前眼压在2例患者中低于10mmHg,而在3例患者中眼压为25mmHg或更高,这些患者有局限性、缺血性、薄壁渗漏滤过泡,周围有广泛瘢痕组织。AMT辅助滤过泡修补术后的随访时间中位数(范围)为49(41 - 67)个月。所有患者术后眼压无需药物治疗或最多使用三种青光眼药物即可得到良好控制。在整个随访期间,没有患者出现滤过泡渗漏复发或与AMT相关的并发症。所有患者在最后一次随访时均显示有一个弥漫性滤过泡,向后延伸超过结膜切口线。
AMT辅助滤过泡修补术成功治疗了难治性迟发性滤过泡渗漏。需要进一步的对照研究来证实目前的结果。